Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVNT | Common Stock | Options Exercise | $358K | +9.1K | +72.94% | $39.37 | 21.6K | Nov 12, 2021 | Direct | |
transaction | AVNT | Common Stock | Disposed to Issuer | -$411K | -6.95K | -32.21% | $59.17 | 14.6K | Nov 12, 2021 | Direct | |
transaction | AVNT | Common Stock | Options Exercise | $297K | +11.9K | +81.36% | $24.98 | 26.5K | Nov 12, 2021 | Direct | |
transaction | AVNT | Common Stock | Disposed to Issuer | -$437K | -7.38K | -27.82% | $59.17 | 19.1K | Nov 12, 2021 | Direct | |
holding | AVNT | Common Stock | 4.07K | Nov 12, 2021 | Supplemental Plan | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -9.1K | -100% | $0.00* | 0 | Nov 12, 2021 | Common Stock | 9.1K | $39.37 | Direct | F2 |
transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -11.9K | -100% | $0.00* | 0 | Nov 12, 2021 | Common Stock | 11.9K | $24.98 | Direct | F3 |
Id | Content |
---|---|
F1 | The information in this report is based on a plan statement as of November 12, 2021. |
F2 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from a market value per share of $39.37 and no more than one-third of the grant can vest per year during the first three years. |
F3 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years. |